معرفی
Dr. Sonja Baumli is a researcher affiliated with Newcastle University, focusing on cyclin-dependent kinases (CDKs), particularly CDK9, as critical targets for pharmacological and virological studies. Her work spans structural and functional analyses of CDK9 inhibitors, viral protein interactions, and transcription regulation.
- Key Research Areas: Molecular Biology, Structural Biology, Pharmacology, Virology, Cancer Biology.
Publication Trends reveal a strong emphasis on CDK9's role in transcription elongation, viral pathogenesis, and cancer therapy. Notably, she has explored the structural basis for inhibitor selectivity and mechanisms of apoptosis induction in neuroblastoma cells.
Collaborations include prominent researchers such as Professor Jane Endicott and Professor Martin Noble, contributing to studies on kinase inhibition and transcriptional regulation.
